Competition, Limiting Reimbursement, Prescription Pattern and It$S Prognosis - Evidence on Taiwan$S Osteoporotic Medication.

This project uses data from National Health Insurance Research dataset to evaluate the impact of limiting reimbursement of osteoporotic medication on physician’s prescription behavior and patients’ prognosis (re-fracture after a certain period). This project also estimates the impact of market competition on the impacts including patient’s prognosis (re-fracture after a certain period) and physician’s prescription behavior after policy. Data are from Longitudinal Health Insurance Database of NHIRD data set from 1996-2014. In order to evaluate all hypothesis in this project, this study uses a series of estimation including nonlinear probability models such as logit model or probit model, and generalized linear model(GLM) to estimates all policy effects.

Project ID:PF10607-1680
External Project ID:MOST106-2410-H182-021